Household & Personal Products

Kimberly‑Clark’s disciplined brand‑investment and steady dividend growth make it a top‑choice consumer‑staple stock poised for upside.

Bioxyne Limited’s latest filings show a dual strategy to raise cash and boost market visibility amid low share prices, offering investors a detailed look at the company’s capital‑raising tactics and regulatory transparency.

Henkel’s share‑buyback boosts EPS and signals confidence in its €28.4 billion market cap, positioning the consumer‑staples firm for stronger shareholder returns amid a rising DAX.

JPMorgan cuts e.l.f. Beauty’s target to $103, citing high valuation and margin risks—will the brand’s growth win back investor confidence?

WD‑40’s 2025 dividend boost to $3.70 per share lifts its yield to 1.71% and highlights a 22% loss for 2020 investors, underscoring the stock’s volatility within consumer staples.

BellRing Brands’ stock dips 61% from its 52‑week high as investors await new guidance amid a quiet market period.

CV Sciences Inc. sees volatile OTC stock, blending consumer personal‑care and specialty pharma; investors watch its low‑priced, loss‑bearing outlook.

Bonk Inc. shifts 51% of fees to BNKK token buy‑backs, boosting supply control and liquidity while launching a regulated ETP on SIX Swiss to attract institutional investors.

Explore Kenvue Inc.’s 2025 stock performance, valuation metrics and growth strategy, and discover why investors watch its consumer health dynamics.

How Kenvue’s stock surged on Nov 23 amid takeover whispers – explore the market reaction, key analysts’ insights, and what this could mean for investors.